Zepp Health Corp. Self-Branded Product Line Ranked No. 4 in First Quarter Global Shipment

BEIJING, June 2, 2021 /PRNewswire/ — Zepp Health Corp. (NYSE: ZEPP), a cloud-based healthcare services provider with world-leading smart wearable technology, today announced that its Amazfit and Zepp-branded products were among the top four in global shipment for the first time in the first quarter of 2021, according to data from the International Data Corporation (IDC) Worldwide Quarterly Wearable Device Tracker.

While the impact of the COVID-19 pandemic still lingers across the world, Zepp’s self-branded watch continued to be favoured by international users in many different countries, demonstrating its competitiveness, resilience and universal product appeal. Zepp health has strong and established market leadership positions in many countries, especially in Brazil, Russia and Spain where its self-branded products ranked first with 40.9%, 28.9%, and 23.5% market share, respectively, according to IDC data for the first quarter of 2021.

About Zepp Health Corporation (NYSE: ZEPP)

Zepp Health changed its name from Huami Corp. (HMI) on February 25, 2021 to emphasize its health focus with a name that resonates cross languages and cultures globally.  The company’s mission continues to be connecting health with technology. Since its inception in 2013, Zepp Health has developed a platform of proprietary technology including AI chips, biometric sensors, and data algorithms, which drive a broadening line of smart health devices for consumers, data analytics services for population health, and industrial medical technology for diagnostics and care delivery. Zepp Health is one of the largest global developers of smart wearable health and consumer fitness devices, shipping 46 million units in 2020. Zepp Health Corp. is based in Hefei, China, with U.S. operations, Zepp Health USA, based in Cupertino, Calif.

Safe Harbor Statement

This announcement contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “confident” and similar statements. Statements that are not historical facts, including statements about the Company’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the cooperation with Xiaomi, the recognition of the Company’s self-branded products; the Company’s growth strategies; trends and competition in global wearable technology market; changes in the Company’s revenues and certain cost or expense accounting policies; governmental policies relating to the Company’s industry and general economic conditions in China and the global. Further information regarding these and other risks is included in the Company’s filings with the United States Securities and Exchange Commission. All information provided in this press release and in the attachments is as of the date of this press release, and the Company undertakes no obligation to update any forward-looking statement, except as required under applicable law.

For investor and media inquiries, please contact:

In China:
Zepp Health Corp.
Grace Yujia Zhang
E-mail: ir@zepp.com

The Piacente Group, Inc.
Yang Song
Tel: +86-10-6508-0677
E-mail: zepp@tpg-ir.com

In the United States:
Zepp Health Corp.
Brad Samson
Tel: 1+714-955-3951
E-mail: brad.samson@zepp-usa.com

View original content:http://www.prnewswire.com/news-releases/zepp-health-corp-self-branded-product-line-ranked-no-4-in-first-quarter-global-shipment-301303833.html

SOURCE Zepp Health Corp.